nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA9—hematologic cancer	0.222	1	CbGaD
Topiramate—CA6—Imatinib—hematologic cancer	0.0372	0.0829	CbGbCtD
Topiramate—CA6—Nilotinib—hematologic cancer	0.0338	0.0754	CbGbCtD
Topiramate—CA7—Imatinib—hematologic cancer	0.0324	0.0723	CbGbCtD
Topiramate—CA7—Nilotinib—hematologic cancer	0.0295	0.0657	CbGbCtD
Topiramate—CA12—Imatinib—hematologic cancer	0.0278	0.062	CbGbCtD
Topiramate—CA9—Imatinib—hematologic cancer	0.0278	0.062	CbGbCtD
Topiramate—CA1—Imatinib—hematologic cancer	0.026	0.058	CbGbCtD
Topiramate—CA12—Nilotinib—hematologic cancer	0.0253	0.0564	CbGbCtD
Topiramate—CA9—Nilotinib—hematologic cancer	0.0253	0.0564	CbGbCtD
Topiramate—CA1—Nilotinib—hematologic cancer	0.0236	0.0527	CbGbCtD
Topiramate—CA2—Imatinib—hematologic cancer	0.0225	0.0502	CbGbCtD
Topiramate—CA4—Nilotinib—hematologic cancer	0.0222	0.0496	CbGbCtD
Topiramate—CA2—Nilotinib—hematologic cancer	0.0204	0.0456	CbGbCtD
Topiramate—CYP2C19—Bortezomib—hematologic cancer	0.00652	0.0145	CbGbCtD
Topiramate—CYP2C19—Thalidomide—hematologic cancer	0.00568	0.0127	CbGbCtD
Topiramate—CYP2C19—Teniposide—hematologic cancer	0.00542	0.0121	CbGbCtD
Topiramate—CYP3A4—Bexarotene—hematologic cancer	0.00514	0.0115	CbGbCtD
Topiramate—CYP2C19—Ifosfamide—hematologic cancer	0.005	0.0112	CbGbCtD
Topiramate—CYP3A4—Lomustine—hematologic cancer	0.00478	0.0107	CbGbCtD
Topiramate—CYP3A4—Busulfan—hematologic cancer	0.00478	0.0107	CbGbCtD
Topiramate—CYP2C19—Imatinib—hematologic cancer	0.00478	0.0107	CbGbCtD
Topiramate—CYP3A4—Thiotepa—hematologic cancer	0.00426	0.00951	CbGbCtD
Topiramate—CYP3A4—Methoxsalen—hematologic cancer	0.00331	0.00739	CbGbCtD
Topiramate—CYP3A4—Bortezomib—hematologic cancer	0.00315	0.00703	CbGbCtD
Topiramate—CYP2C19—Prednisone—hematologic cancer	0.00315	0.00702	CbGbCtD
Topiramate—CYP3A4—Daunorubicin—hematologic cancer	0.00302	0.00673	CbGbCtD
Topiramate—CYP3A4—Cytarabine—hematologic cancer	0.00266	0.00593	CbGbCtD
Topiramate—CYP3A4—Teniposide—hematologic cancer	0.00262	0.00584	CbGbCtD
Topiramate—CYP3A4—Ifosfamide—hematologic cancer	0.00242	0.00539	CbGbCtD
Topiramate—CYP3A4—Imatinib—hematologic cancer	0.00231	0.00515	CbGbCtD
Topiramate—GRIK4—testis—hematologic cancer	0.0023	0.0878	CbGeAlD
Topiramate—CYP3A4—Ruxolitinib—hematologic cancer	0.00218	0.00485	CbGbCtD
Topiramate—CYP3A4—Nilotinib—hematologic cancer	0.0021	0.00468	CbGbCtD
Topiramate—CYP3A4—Vinorelbine—hematologic cancer	0.00208	0.00464	CbGbCtD
Topiramate—CYP2C19—Dexamethasone—hematologic cancer	0.00197	0.00438	CbGbCtD
Topiramate—CYP3A4—Triamcinolone—hematologic cancer	0.0019	0.00425	CbGbCtD
Topiramate—CYP3A4—Dasatinib—hematologic cancer	0.00186	0.00414	CbGbCtD
Topiramate—CYP3A4—Mitoxantrone—hematologic cancer	0.00183	0.00409	CbGbCtD
Topiramate—GRIK3—testis—hematologic cancer	0.00168	0.0641	CbGeAlD
Topiramate—GRIK5—testis—hematologic cancer	0.00168	0.0641	CbGeAlD
Topiramate—CYP3A4—Betamethasone—hematologic cancer	0.00163	0.00364	CbGbCtD
Topiramate—CYP3A4—Prednisolone—hematologic cancer	0.00161	0.00359	CbGbCtD
Topiramate—CYP3A4—Prednisone—hematologic cancer	0.00152	0.00339	CbGbCtD
Topiramate—GRIA3—testis—hematologic cancer	0.00148	0.0566	CbGeAlD
Topiramate—CYP3A4—Irinotecan—hematologic cancer	0.00144	0.00322	CbGbCtD
Topiramate—CYP3A4—Vinblastine—hematologic cancer	0.00128	0.00286	CbGbCtD
Topiramate—CYP3A4—Vincristine—hematologic cancer	0.00126	0.00281	CbGbCtD
Topiramate—GRIK3—lymph node—hematologic cancer	0.00122	0.0465	CbGeAlD
Topiramate—GRIK5—lymph node—hematologic cancer	0.00122	0.0465	CbGeAlD
Topiramate—CYP3A4—Etoposide—hematologic cancer	0.00116	0.00258	CbGbCtD
Topiramate—CYP3A4—Dexamethasone—hematologic cancer	0.00095	0.00212	CbGbCtD
Topiramate—CA5B—hematopoietic system—hematologic cancer	0.000869	0.0332	CbGeAlD
Topiramate—GRIA1—lung—hematologic cancer	0.000839	0.032	CbGeAlD
Topiramate—GRIA1—testis—hematologic cancer	0.000792	0.0302	CbGeAlD
Topiramate—CYP3A4—Doxorubicin—hematologic cancer	0.000788	0.00176	CbGbCtD
Topiramate—CA1—hematopoietic system—hematologic cancer	0.000768	0.0293	CbGeAlD
Topiramate—CA9—testis—hematologic cancer	0.000718	0.0274	CbGeAlD
Topiramate—CA5B—gonad—hematologic cancer	0.000661	0.0252	CbGeAlD
Topiramate—GRIA2—testis—hematologic cancer	0.000629	0.024	CbGeAlD
Topiramate—SCN1A—lung—hematologic cancer	0.000608	0.0232	CbGeAlD
Topiramate—CA5B—blood—hematologic cancer	0.000576	0.022	CbGeAlD
Topiramate—CA12—lung—hematologic cancer	0.000563	0.0215	CbGeAlD
Topiramate—SCN5A—blood—hematologic cancer	0.000558	0.0213	CbGeAlD
Topiramate—CYP2C19—hematopoietic system—hematologic cancer	0.000543	0.0207	CbGeAlD
Topiramate—CA1—blood—hematologic cancer	0.000509	0.0194	CbGeAlD
Topiramate—CA5B—lung—hematologic cancer	0.000505	0.0193	CbGeAlD
Topiramate—CA2—hematopoietic system—hematologic cancer	0.000498	0.019	CbGeAlD
Topiramate—CA1—bone marrow—hematologic cancer	0.000492	0.0188	CbGeAlD
Topiramate—CA5B—testis—hematologic cancer	0.000476	0.0182	CbGeAlD
Topiramate—GABRB2—lung—hematologic cancer	0.000474	0.0181	CbGeAlD
Topiramate—GABRB2—testis—hematologic cancer	0.000447	0.0171	CbGeAlD
Topiramate—CA1—lung—hematologic cancer	0.000446	0.017	CbGeAlD
Topiramate—CA4—blood—hematologic cancer	0.000398	0.0152	CbGeAlD
Topiramate—CA4—bone marrow—hematologic cancer	0.000385	0.0147	CbGeAlD
Topiramate—CYP2C19—blood—hematologic cancer	0.00036	0.0137	CbGeAlD
Topiramate—CA4—lung—hematologic cancer	0.000349	0.0133	CbGeAlD
Topiramate—CA5B—lymph node—hematologic cancer	0.000345	0.0132	CbGeAlD
Topiramate—CA2—blood—hematologic cancer	0.00033	0.0126	CbGeAlD
Topiramate—CA4—testis—hematologic cancer	0.000329	0.0126	CbGeAlD
Topiramate—CYP3A4—hematopoietic system—hematologic cancer	0.000321	0.0123	CbGeAlD
Topiramate—CA2—bone marrow—hematologic cancer	0.000319	0.0122	CbGeAlD
Topiramate—CA1—lymph node—hematologic cancer	0.000305	0.0116	CbGeAlD
Topiramate—CA2—lung—hematologic cancer	0.000289	0.011	CbGeAlD
Topiramate—CA2—testis—hematologic cancer	0.000273	0.0104	CbGeAlD
Topiramate—CA4—lymph node—hematologic cancer	0.000238	0.0091	CbGeAlD
Topiramate—CYP3A4—blood—hematologic cancer	0.000213	0.00812	CbGeAlD
Topiramate—CA2—lymph node—hematologic cancer	0.000198	0.00754	CbGeAlD
Topiramate—Feeling abnormal—Betamethasone—hematologic cancer	9.34e-06	4.24e-05	CcSEcCtD
Topiramate—Feeling abnormal—Dexamethasone—hematologic cancer	9.34e-06	4.24e-05	CcSEcCtD
Topiramate—Flushing—Doxorubicin—hematologic cancer	9.33e-06	4.24e-05	CcSEcCtD
Topiramate—Cardiac disorder—Doxorubicin—hematologic cancer	9.33e-06	4.24e-05	CcSEcCtD
Topiramate—Flatulence—Epirubicin—hematologic cancer	9.32e-06	4.24e-05	CcSEcCtD
Topiramate—Tension—Epirubicin—hematologic cancer	9.28e-06	4.22e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Dexamethasone—hematologic cancer	9.27e-06	4.21e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Betamethasone—hematologic cancer	9.27e-06	4.21e-05	CcSEcCtD
Topiramate—Dysgeusia—Epirubicin—hematologic cancer	9.26e-06	4.21e-05	CcSEcCtD
Topiramate—Hypersensitivity—Triamcinolone—hematologic cancer	9.2e-06	4.18e-05	CcSEcCtD
Topiramate—Nervousness—Epirubicin—hematologic cancer	9.19e-06	4.18e-05	CcSEcCtD
Topiramate—Back pain—Epirubicin—hematologic cancer	9.15e-06	4.16e-05	CcSEcCtD
Topiramate—Angiopathy—Doxorubicin—hematologic cancer	9.12e-06	4.15e-05	CcSEcCtD
Topiramate—Malaise—Methotrexate—hematologic cancer	9.12e-06	4.14e-05	CcSEcCtD
Topiramate—Dizziness—Etoposide—hematologic cancer	9.11e-06	4.14e-05	CcSEcCtD
Topiramate—Muscle spasms—Epirubicin—hematologic cancer	9.09e-06	4.13e-05	CcSEcCtD
Topiramate—Immune system disorder—Doxorubicin—hematologic cancer	9.08e-06	4.13e-05	CcSEcCtD
Topiramate—Vertigo—Methotrexate—hematologic cancer	9.08e-06	4.13e-05	CcSEcCtD
Topiramate—Mediastinal disorder—Doxorubicin—hematologic cancer	9.06e-06	4.12e-05	CcSEcCtD
Topiramate—Leukopenia—Methotrexate—hematologic cancer	9.05e-06	4.11e-05	CcSEcCtD
Topiramate—Chills—Doxorubicin—hematologic cancer	9.02e-06	4.1e-05	CcSEcCtD
Topiramate—Urticaria—Dexamethasone—hematologic cancer	9e-06	4.09e-05	CcSEcCtD
Topiramate—Urticaria—Betamethasone—hematologic cancer	9e-06	4.09e-05	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Prednisone—hematologic cancer	8.99e-06	4.09e-05	CcSEcCtD
Topiramate—Dizziness—Prednisolone—hematologic cancer	8.98e-06	4.08e-05	CcSEcCtD
Topiramate—Asthenia—Triamcinolone—hematologic cancer	8.96e-06	4.07e-05	CcSEcCtD
Topiramate—Body temperature increased—Dexamethasone—hematologic cancer	8.96e-06	4.07e-05	CcSEcCtD
Topiramate—Abdominal pain—Dexamethasone—hematologic cancer	8.96e-06	4.07e-05	CcSEcCtD
Topiramate—Abdominal pain—Betamethasone—hematologic cancer	8.96e-06	4.07e-05	CcSEcCtD
Topiramate—Body temperature increased—Betamethasone—hematologic cancer	8.96e-06	4.07e-05	CcSEcCtD
Topiramate—Nausea—Cisplatin—hematologic cancer	8.93e-06	4.06e-05	CcSEcCtD
Topiramate—Insomnia—Prednisone—hematologic cancer	8.93e-06	4.06e-05	CcSEcCtD
Topiramate—Vision blurred—Epirubicin—hematologic cancer	8.91e-06	4.05e-05	CcSEcCtD
Topiramate—Alopecia—Doxorubicin—hematologic cancer	8.88e-06	4.04e-05	CcSEcCtD
Topiramate—Paraesthesia—Prednisone—hematologic cancer	8.86e-06	4.03e-05	CcSEcCtD
Topiramate—Pruritus—Triamcinolone—hematologic cancer	8.84e-06	4.02e-05	CcSEcCtD
Topiramate—Cough—Methotrexate—hematologic cancer	8.82e-06	4.01e-05	CcSEcCtD
Topiramate—Mental disorder—Doxorubicin—hematologic cancer	8.81e-06	4e-05	CcSEcCtD
Topiramate—Ill-defined disorder—Epirubicin—hematologic cancer	8.78e-06	3.99e-05	CcSEcCtD
Topiramate—Convulsion—Methotrexate—hematologic cancer	8.76e-06	3.98e-05	CcSEcCtD
Topiramate—Vomiting—Etoposide—hematologic cancer	8.76e-06	3.98e-05	CcSEcCtD
Topiramate—Malnutrition—Doxorubicin—hematologic cancer	8.75e-06	3.98e-05	CcSEcCtD
Topiramate—Erythema—Doxorubicin—hematologic cancer	8.75e-06	3.98e-05	CcSEcCtD
Topiramate—Anaemia—Epirubicin—hematologic cancer	8.74e-06	3.97e-05	CcSEcCtD
Topiramate—Agitation—Epirubicin—hematologic cancer	8.69e-06	3.95e-05	CcSEcCtD
Topiramate—Dyspepsia—Prednisone—hematologic cancer	8.69e-06	3.95e-05	CcSEcCtD
Topiramate—Rash—Etoposide—hematologic cancer	8.68e-06	3.95e-05	CcSEcCtD
Topiramate—Dermatitis—Etoposide—hematologic cancer	8.68e-06	3.94e-05	CcSEcCtD
Topiramate—Headache—Etoposide—hematologic cancer	8.63e-06	3.92e-05	CcSEcCtD
Topiramate—Flatulence—Doxorubicin—hematologic cancer	8.62e-06	3.92e-05	CcSEcCtD
Topiramate—Arthralgia—Methotrexate—hematologic cancer	8.61e-06	3.91e-05	CcSEcCtD
Topiramate—Chest pain—Methotrexate—hematologic cancer	8.61e-06	3.91e-05	CcSEcCtD
Topiramate—Myalgia—Methotrexate—hematologic cancer	8.61e-06	3.91e-05	CcSEcCtD
Topiramate—Tension—Doxorubicin—hematologic cancer	8.59e-06	3.9e-05	CcSEcCtD
Topiramate—Decreased appetite—Prednisone—hematologic cancer	8.58e-06	3.9e-05	CcSEcCtD
Topiramate—Dysgeusia—Doxorubicin—hematologic cancer	8.57e-06	3.9e-05	CcSEcCtD
Topiramate—Rash—Prednisolone—hematologic cancer	8.56e-06	3.89e-05	CcSEcCtD
Topiramate—Dermatitis—Prednisolone—hematologic cancer	8.56e-06	3.89e-05	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	8.55e-06	3.88e-05	CcSEcCtD
Topiramate—Malaise—Epirubicin—hematologic cancer	8.53e-06	3.88e-05	CcSEcCtD
Topiramate—Fatigue—Prednisone—hematologic cancer	8.51e-06	3.87e-05	CcSEcCtD
Topiramate—Headache—Prednisolone—hematologic cancer	8.51e-06	3.87e-05	CcSEcCtD
Topiramate—Discomfort—Methotrexate—hematologic cancer	8.5e-06	3.86e-05	CcSEcCtD
Topiramate—Nervousness—Doxorubicin—hematologic cancer	8.5e-06	3.86e-05	CcSEcCtD
Topiramate—Vertigo—Epirubicin—hematologic cancer	8.5e-06	3.86e-05	CcSEcCtD
Topiramate—Syncope—Epirubicin—hematologic cancer	8.48e-06	3.85e-05	CcSEcCtD
Topiramate—Leukopenia—Epirubicin—hematologic cancer	8.47e-06	3.85e-05	CcSEcCtD
Topiramate—Back pain—Doxorubicin—hematologic cancer	8.47e-06	3.85e-05	CcSEcCtD
Topiramate—Constipation—Prednisone—hematologic cancer	8.44e-06	3.84e-05	CcSEcCtD
Topiramate—Muscle spasms—Doxorubicin—hematologic cancer	8.41e-06	3.82e-05	CcSEcCtD
Topiramate—Palpitations—Epirubicin—hematologic cancer	8.36e-06	3.8e-05	CcSEcCtD
Topiramate—Confusional state—Methotrexate—hematologic cancer	8.32e-06	3.78e-05	CcSEcCtD
Topiramate—Loss of consciousness—Epirubicin—hematologic cancer	8.31e-06	3.78e-05	CcSEcCtD
Topiramate—Dizziness—Triamcinolone—hematologic cancer	8.26e-06	3.75e-05	CcSEcCtD
Topiramate—Cough—Epirubicin—hematologic cancer	8.25e-06	3.75e-05	CcSEcCtD
Topiramate—Vision blurred—Doxorubicin—hematologic cancer	8.25e-06	3.75e-05	CcSEcCtD
Topiramate—Convulsion—Epirubicin—hematologic cancer	8.2e-06	3.72e-05	CcSEcCtD
Topiramate—Infection—Methotrexate—hematologic cancer	8.2e-06	3.72e-05	CcSEcCtD
Topiramate—Nausea—Etoposide—hematologic cancer	8.18e-06	3.72e-05	CcSEcCtD
Topiramate—Hypertension—Epirubicin—hematologic cancer	8.17e-06	3.71e-05	CcSEcCtD
Topiramate—Feeling abnormal—Prednisone—hematologic cancer	8.13e-06	3.7e-05	CcSEcCtD
Topiramate—Asthenia—Betamethasone—hematologic cancer	8.13e-06	3.7e-05	CcSEcCtD
Topiramate—Asthenia—Dexamethasone—hematologic cancer	8.13e-06	3.7e-05	CcSEcCtD
Topiramate—Ill-defined disorder—Doxorubicin—hematologic cancer	8.12e-06	3.69e-05	CcSEcCtD
Topiramate—Nervous system disorder—Methotrexate—hematologic cancer	8.09e-06	3.68e-05	CcSEcCtD
Topiramate—Anaemia—Doxorubicin—hematologic cancer	8.09e-06	3.68e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Methotrexate—hematologic cancer	8.08e-06	3.67e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Prednisone—hematologic cancer	8.07e-06	3.67e-05	CcSEcCtD
Topiramate—Nausea—Prednisolone—hematologic cancer	8.07e-06	3.67e-05	CcSEcCtD
Topiramate—Myalgia—Epirubicin—hematologic cancer	8.05e-06	3.66e-05	CcSEcCtD
Topiramate—Arthralgia—Epirubicin—hematologic cancer	8.05e-06	3.66e-05	CcSEcCtD
Topiramate—Chest pain—Epirubicin—hematologic cancer	8.05e-06	3.66e-05	CcSEcCtD
Topiramate—Agitation—Doxorubicin—hematologic cancer	8.04e-06	3.66e-05	CcSEcCtD
Topiramate—Anxiety—Epirubicin—hematologic cancer	8.03e-06	3.65e-05	CcSEcCtD
Topiramate—Pruritus—Dexamethasone—hematologic cancer	8.02e-06	3.64e-05	CcSEcCtD
Topiramate—Pruritus—Betamethasone—hematologic cancer	8.02e-06	3.64e-05	CcSEcCtD
Topiramate—Skin disorder—Methotrexate—hematologic cancer	8.01e-06	3.64e-05	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	8e-06	3.63e-05	CcSEcCtD
Topiramate—Hyperhidrosis—Methotrexate—hematologic cancer	7.97e-06	3.62e-05	CcSEcCtD
Topiramate—Discomfort—Epirubicin—hematologic cancer	7.96e-06	3.62e-05	CcSEcCtD
Topiramate—Vomiting—Triamcinolone—hematologic cancer	7.94e-06	3.61e-05	CcSEcCtD
Topiramate—Malaise—Doxorubicin—hematologic cancer	7.89e-06	3.59e-05	CcSEcCtD
Topiramate—Rash—Triamcinolone—hematologic cancer	7.88e-06	3.58e-05	CcSEcCtD
Topiramate—Dry mouth—Epirubicin—hematologic cancer	7.88e-06	3.58e-05	CcSEcCtD
Topiramate—Dermatitis—Triamcinolone—hematologic cancer	7.87e-06	3.58e-05	CcSEcCtD
Topiramate—Vertigo—Doxorubicin—hematologic cancer	7.86e-06	3.57e-05	CcSEcCtD
Topiramate—Anorexia—Methotrexate—hematologic cancer	7.86e-06	3.57e-05	CcSEcCtD
Topiramate—Syncope—Doxorubicin—hematologic cancer	7.85e-06	3.57e-05	CcSEcCtD
Topiramate—Urticaria—Prednisone—hematologic cancer	7.84e-06	3.56e-05	CcSEcCtD
Topiramate—Leukopenia—Doxorubicin—hematologic cancer	7.83e-06	3.56e-05	CcSEcCtD
Topiramate—Headache—Triamcinolone—hematologic cancer	7.83e-06	3.56e-05	CcSEcCtD
Topiramate—Abdominal pain—Prednisone—hematologic cancer	7.8e-06	3.55e-05	CcSEcCtD
Topiramate—Body temperature increased—Prednisone—hematologic cancer	7.8e-06	3.55e-05	CcSEcCtD
Topiramate—Confusional state—Epirubicin—hematologic cancer	7.78e-06	3.54e-05	CcSEcCtD
Topiramate—Diarrhoea—Dexamethasone—hematologic cancer	7.76e-06	3.52e-05	CcSEcCtD
Topiramate—Diarrhoea—Betamethasone—hematologic cancer	7.76e-06	3.52e-05	CcSEcCtD
Topiramate—Palpitations—Doxorubicin—hematologic cancer	7.73e-06	3.51e-05	CcSEcCtD
Topiramate—Oedema—Epirubicin—hematologic cancer	7.72e-06	3.51e-05	CcSEcCtD
Topiramate—Hypotension—Methotrexate—hematologic cancer	7.71e-06	3.5e-05	CcSEcCtD
Topiramate—Loss of consciousness—Doxorubicin—hematologic cancer	7.69e-06	3.5e-05	CcSEcCtD
Topiramate—Infection—Epirubicin—hematologic cancer	7.67e-06	3.49e-05	CcSEcCtD
Topiramate—Cough—Doxorubicin—hematologic cancer	7.64e-06	3.47e-05	CcSEcCtD
Topiramate—Shock—Epirubicin—hematologic cancer	7.6e-06	3.45e-05	CcSEcCtD
Topiramate—Convulsion—Doxorubicin—hematologic cancer	7.58e-06	3.45e-05	CcSEcCtD
Topiramate—Nervous system disorder—Epirubicin—hematologic cancer	7.57e-06	3.44e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Epirubicin—hematologic cancer	7.56e-06	3.43e-05	CcSEcCtD
Topiramate—Hypertension—Doxorubicin—hematologic cancer	7.56e-06	3.43e-05	CcSEcCtD
Topiramate—Tachycardia—Epirubicin—hematologic cancer	7.53e-06	3.42e-05	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	7.52e-06	3.42e-05	CcSEcCtD
Topiramate—Skin disorder—Epirubicin—hematologic cancer	7.5e-06	3.41e-05	CcSEcCtD
Topiramate—Dizziness—Betamethasone—hematologic cancer	7.5e-06	3.41e-05	CcSEcCtD
Topiramate—Dizziness—Dexamethasone—hematologic cancer	7.5e-06	3.41e-05	CcSEcCtD
Topiramate—Hyperhidrosis—Epirubicin—hematologic cancer	7.46e-06	3.39e-05	CcSEcCtD
Topiramate—Insomnia—Methotrexate—hematologic cancer	7.46e-06	3.39e-05	CcSEcCtD
Topiramate—Arthralgia—Doxorubicin—hematologic cancer	7.45e-06	3.39e-05	CcSEcCtD
Topiramate—Chest pain—Doxorubicin—hematologic cancer	7.45e-06	3.39e-05	CcSEcCtD
Topiramate—Myalgia—Doxorubicin—hematologic cancer	7.45e-06	3.39e-05	CcSEcCtD
Topiramate—Anxiety—Doxorubicin—hematologic cancer	7.43e-06	3.37e-05	CcSEcCtD
Topiramate—Nausea—Triamcinolone—hematologic cancer	7.42e-06	3.37e-05	CcSEcCtD
Topiramate—Paraesthesia—Methotrexate—hematologic cancer	7.41e-06	3.37e-05	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	7.4e-06	3.36e-05	CcSEcCtD
Topiramate—Discomfort—Doxorubicin—hematologic cancer	7.36e-06	3.35e-05	CcSEcCtD
Topiramate—Anorexia—Epirubicin—hematologic cancer	7.36e-06	3.34e-05	CcSEcCtD
Topiramate—Dyspnoea—Methotrexate—hematologic cancer	7.35e-06	3.34e-05	CcSEcCtD
Topiramate—Somnolence—Methotrexate—hematologic cancer	7.33e-06	3.33e-05	CcSEcCtD
Topiramate—Dry mouth—Doxorubicin—hematologic cancer	7.29e-06	3.31e-05	CcSEcCtD
Topiramate—Hypersensitivity—Prednisone—hematologic cancer	7.27e-06	3.3e-05	CcSEcCtD
Topiramate—Dyspepsia—Methotrexate—hematologic cancer	7.26e-06	3.3e-05	CcSEcCtD
Topiramate—Hypotension—Epirubicin—hematologic cancer	7.21e-06	3.28e-05	CcSEcCtD
Topiramate—CA12—Metabolism—PIK3CG—hematologic cancer	7.21e-06	8.66e-05	CbGpPWpGaD
Topiramate—Vomiting—Betamethasone—hematologic cancer	7.21e-06	3.27e-05	CcSEcCtD
Topiramate—Vomiting—Dexamethasone—hematologic cancer	7.21e-06	3.27e-05	CcSEcCtD
Topiramate—Confusional state—Doxorubicin—hematologic cancer	7.2e-06	3.27e-05	CcSEcCtD
Topiramate—Decreased appetite—Methotrexate—hematologic cancer	7.17e-06	3.26e-05	CcSEcCtD
Topiramate—Rash—Betamethasone—hematologic cancer	7.15e-06	3.25e-05	CcSEcCtD
Topiramate—Rash—Dexamethasone—hematologic cancer	7.15e-06	3.25e-05	CcSEcCtD
Topiramate—Oedema—Doxorubicin—hematologic cancer	7.14e-06	3.25e-05	CcSEcCtD
Topiramate—Dermatitis—Dexamethasone—hematologic cancer	7.14e-06	3.24e-05	CcSEcCtD
Topiramate—Dermatitis—Betamethasone—hematologic cancer	7.14e-06	3.24e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Methotrexate—hematologic cancer	7.12e-06	3.24e-05	CcSEcCtD
Topiramate—CA1—Metabolism—NCOR1—hematologic cancer	7.12e-06	8.54e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTM1—hematologic cancer	7.12e-06	8.54e-05	CbGpPWpGaD
Topiramate—Fatigue—Methotrexate—hematologic cancer	7.11e-06	3.23e-05	CcSEcCtD
Topiramate—Headache—Dexamethasone—hematologic cancer	7.1e-06	3.23e-05	CcSEcCtD
Topiramate—Headache—Betamethasone—hematologic cancer	7.1e-06	3.23e-05	CcSEcCtD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	7.1e-06	8.52e-05	CbGpPWpGaD
Topiramate—Infection—Doxorubicin—hematologic cancer	7.1e-06	3.22e-05	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—HRAS—hematologic cancer	7.09e-06	8.51e-05	CbGpPWpGaD
Topiramate—Asthenia—Prednisone—hematologic cancer	7.08e-06	3.22e-05	CcSEcCtD
Topiramate—Pain—Methotrexate—hematologic cancer	7.05e-06	3.21e-05	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—TNF—hematologic cancer	7.04e-06	8.45e-05	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	7.03e-06	3.2e-05	CcSEcCtD
Topiramate—Shock—Doxorubicin—hematologic cancer	7.03e-06	3.19e-05	CcSEcCtD
Topiramate—Nervous system disorder—Doxorubicin—hematologic cancer	7.01e-06	3.18e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Doxorubicin—hematologic cancer	6.99e-06	3.18e-05	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—KRAS—hematologic cancer	6.99e-06	8.39e-05	CbGpPWpGaD
Topiramate—Pruritus—Prednisone—hematologic cancer	6.98e-06	3.17e-05	CcSEcCtD
Topiramate—Insomnia—Epirubicin—hematologic cancer	6.98e-06	3.17e-05	CcSEcCtD
Topiramate—Tachycardia—Doxorubicin—hematologic cancer	6.97e-06	3.17e-05	CcSEcCtD
Topiramate—Skin disorder—Doxorubicin—hematologic cancer	6.94e-06	3.15e-05	CcSEcCtD
Topiramate—Paraesthesia—Epirubicin—hematologic cancer	6.93e-06	3.15e-05	CcSEcCtD
Topiramate—CA6—Metabolism—PIK3R1—hematologic cancer	6.92e-06	8.31e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3R1—hematologic cancer	6.92e-06	8.31e-05	CbGpPWpGaD
Topiramate—Hyperhidrosis—Doxorubicin—hematologic cancer	6.91e-06	3.14e-05	CcSEcCtD
Topiramate—Dyspnoea—Epirubicin—hematologic cancer	6.88e-06	3.13e-05	CcSEcCtD
Topiramate—SCN5A—Axon guidance—KRAS—hematologic cancer	6.88e-06	8.26e-05	CbGpPWpGaD
Topiramate—Somnolence—Epirubicin—hematologic cancer	6.86e-06	3.12e-05	CcSEcCtD
Topiramate—CA4—Metabolism—MTHFR—hematologic cancer	6.84e-06	8.22e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CD—hematologic cancer	6.84e-06	8.21e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CD—hematologic cancer	6.84e-06	8.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DCK—hematologic cancer	6.83e-06	8.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ASNS—hematologic cancer	6.83e-06	8.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—B3GAT1—hematologic cancer	6.83e-06	8.2e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTP1—hematologic cancer	6.81e-06	8.17e-05	CbGpPWpGaD
Topiramate—Anorexia—Doxorubicin—hematologic cancer	6.81e-06	3.09e-05	CcSEcCtD
Topiramate—Feeling abnormal—Methotrexate—hematologic cancer	6.8e-06	3.09e-05	CcSEcCtD
Topiramate—Dyspepsia—Epirubicin—hematologic cancer	6.8e-06	3.09e-05	CcSEcCtD
Topiramate—CA5B—Metabolism—ALB—hematologic cancer	6.75e-06	8.11e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—ALB—hematologic cancer	6.75e-06	8.11e-05	CbGpPWpGaD
Topiramate—Diarrhoea—Prednisone—hematologic cancer	6.75e-06	3.07e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Methotrexate—hematologic cancer	6.75e-06	3.07e-05	CcSEcCtD
Topiramate—Nausea—Betamethasone—hematologic cancer	6.73e-06	3.06e-05	CcSEcCtD
Topiramate—Nausea—Dexamethasone—hematologic cancer	6.73e-06	3.06e-05	CcSEcCtD
Topiramate—Decreased appetite—Epirubicin—hematologic cancer	6.71e-06	3.05e-05	CcSEcCtD
Topiramate—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	6.7e-06	8.05e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—CREBBP—hematologic cancer	6.69e-06	8.03e-05	CbGpPWpGaD
Topiramate—Hypotension—Doxorubicin—hematologic cancer	6.67e-06	3.03e-05	CcSEcCtD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	6.67e-06	8.01e-05	CbGpPWpGaD
Topiramate—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.67e-06	3.03e-05	CcSEcCtD
Topiramate—Fatigue—Epirubicin—hematologic cancer	6.66e-06	3.02e-05	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	6.62e-06	7.95e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	6.61e-06	7.94e-05	CbGpPWpGaD
Topiramate—Pain—Epirubicin—hematologic cancer	6.6e-06	3e-05	CcSEcCtD
Topiramate—Constipation—Epirubicin—hematologic cancer	6.6e-06	3e-05	CcSEcCtD
Topiramate—CA2—Metabolism—MTHFR—hematologic cancer	6.56e-06	7.88e-05	CbGpPWpGaD
Topiramate—Urticaria—Methotrexate—hematologic cancer	6.55e-06	2.98e-05	CcSEcCtD
Topiramate—Dizziness—Prednisone—hematologic cancer	6.53e-06	2.97e-05	CcSEcCtD
Topiramate—Abdominal pain—Methotrexate—hematologic cancer	6.52e-06	2.96e-05	CcSEcCtD
Topiramate—Body temperature increased—Methotrexate—hematologic cancer	6.52e-06	2.96e-05	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.51e-06	2.96e-05	CcSEcCtD
Topiramate—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.49e-06	7.79e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HDC—hematologic cancer	6.47e-06	7.77e-05	CbGpPWpGaD
Topiramate—Insomnia—Doxorubicin—hematologic cancer	6.46e-06	2.94e-05	CcSEcCtD
Topiramate—CA5B—Metabolism—PIK3R1—hematologic cancer	6.46e-06	7.76e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3R1—hematologic cancer	6.46e-06	7.76e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCB1—hematologic cancer	6.45e-06	7.74e-05	CbGpPWpGaD
Topiramate—Paraesthesia—Doxorubicin—hematologic cancer	6.41e-06	2.91e-05	CcSEcCtD
Topiramate—CA6—Metabolism—PIK3CB—hematologic cancer	6.39e-06	7.67e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CB—hematologic cancer	6.39e-06	7.67e-05	CbGpPWpGaD
Topiramate—Dyspnoea—Doxorubicin—hematologic cancer	6.37e-06	2.89e-05	CcSEcCtD
Topiramate—Feeling abnormal—Epirubicin—hematologic cancer	6.36e-06	2.89e-05	CcSEcCtD
Topiramate—Somnolence—Doxorubicin—hematologic cancer	6.35e-06	2.89e-05	CcSEcCtD
Topiramate—CA12—Metabolism—PIK3CD—hematologic cancer	6.34e-06	7.61e-05	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Epirubicin—hematologic cancer	6.31e-06	2.87e-05	CcSEcCtD
Topiramate—CA1—Metabolism—MTHFR—hematologic cancer	6.29e-06	7.55e-05	CbGpPWpGaD
Topiramate—Dyspepsia—Doxorubicin—hematologic cancer	6.29e-06	2.86e-05	CcSEcCtD
Topiramate—Vomiting—Prednisone—hematologic cancer	6.28e-06	2.85e-05	CcSEcCtD
Topiramate—GABRB2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.27e-06	7.52e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—NCOR1—hematologic cancer	6.26e-06	7.51e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTM1—hematologic cancer	6.26e-06	7.51e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—ALB—hematologic cancer	6.26e-06	7.51e-05	CbGpPWpGaD
Topiramate—Rash—Prednisone—hematologic cancer	6.22e-06	2.83e-05	CcSEcCtD
Topiramate—Dermatitis—Prednisone—hematologic cancer	6.22e-06	2.83e-05	CcSEcCtD
Topiramate—Decreased appetite—Doxorubicin—hematologic cancer	6.21e-06	2.82e-05	CcSEcCtD
Topiramate—Headache—Prednisone—hematologic cancer	6.18e-06	2.81e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	6.17e-06	2.8e-05	CcSEcCtD
Topiramate—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	6.16e-06	7.39e-05	CbGpPWpGaD
Topiramate—Fatigue—Doxorubicin—hematologic cancer	6.16e-06	2.8e-05	CcSEcCtD
Topiramate—Urticaria—Epirubicin—hematologic cancer	6.13e-06	2.79e-05	CcSEcCtD
Topiramate—Pain—Doxorubicin—hematologic cancer	6.11e-06	2.78e-05	CcSEcCtD
Topiramate—Constipation—Doxorubicin—hematologic cancer	6.11e-06	2.78e-05	CcSEcCtD
Topiramate—Abdominal pain—Epirubicin—hematologic cancer	6.1e-06	2.77e-05	CcSEcCtD
Topiramate—Body temperature increased—Epirubicin—hematologic cancer	6.1e-06	2.77e-05	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—EP300—hematologic cancer	6.1e-06	7.32e-05	CbGpPWpGaD
Topiramate—Hypersensitivity—Methotrexate—hematologic cancer	6.08e-06	2.76e-05	CcSEcCtD
Topiramate—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	6.07e-06	7.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	6.04e-06	7.25e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3R1—hematologic cancer	5.99e-06	7.19e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CB—hematologic cancer	5.96e-06	7.16e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CB—hematologic cancer	5.96e-06	7.16e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HRAS—hematologic cancer	5.94e-06	7.13e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SRC—hematologic cancer	5.93e-06	7.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CDA—hematologic cancer	5.92e-06	7.11e-05	CbGpPWpGaD
Topiramate—Asthenia—Methotrexate—hematologic cancer	5.92e-06	2.69e-05	CcSEcCtD
Topiramate—Feeling abnormal—Doxorubicin—hematologic cancer	5.89e-06	2.68e-05	CcSEcCtD
Topiramate—GABRB2—Transmembrane transport of small molecules—ALB—hematologic cancer	5.87e-06	7.04e-05	CbGpPWpGaD
Topiramate—Nausea—Prednisone—hematologic cancer	5.86e-06	2.66e-05	CcSEcCtD
Topiramate—SCN5A—Axon guidance—HRAS—hematologic cancer	5.85e-06	7.02e-05	CbGpPWpGaD
Topiramate—Gastrointestinal pain—Doxorubicin—hematologic cancer	5.84e-06	2.65e-05	CcSEcCtD
Topiramate—Pruritus—Methotrexate—hematologic cancer	5.84e-06	2.65e-05	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—VEGFA—hematologic cancer	5.78e-06	6.93e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CG—hematologic cancer	5.75e-06	6.9e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.73e-06	6.88e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—hematologic cancer	5.72e-06	6.87e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NRAS—hematologic cancer	5.71e-06	6.85e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PC—hematologic cancer	5.7e-06	6.84e-05	CbGpPWpGaD
Topiramate—Hypersensitivity—Epirubicin—hematologic cancer	5.69e-06	2.58e-05	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—IL6—hematologic cancer	5.68e-06	6.82e-05	CbGpPWpGaD
Topiramate—Urticaria—Doxorubicin—hematologic cancer	5.67e-06	2.58e-05	CcSEcCtD
Topiramate—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.67e-06	6.81e-05	CbGpPWpGaD
Topiramate—Body temperature increased—Doxorubicin—hematologic cancer	5.65e-06	2.57e-05	CcSEcCtD
Topiramate—Abdominal pain—Doxorubicin—hematologic cancer	5.65e-06	2.57e-05	CcSEcCtD
Topiramate—Diarrhoea—Methotrexate—hematologic cancer	5.64e-06	2.56e-05	CcSEcCtD
Topiramate—SCN5A—Axon guidance—IL6—hematologic cancer	5.6e-06	6.72e-05	CbGpPWpGaD
Topiramate—Asthenia—Epirubicin—hematologic cancer	5.54e-06	2.52e-05	CcSEcCtD
Topiramate—CA9—Metabolism—MTHFR—hematologic cancer	5.53e-06	6.64e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CB—hematologic cancer	5.52e-06	6.63e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTEN—hematologic cancer	5.52e-06	6.63e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTEN—hematologic cancer	5.52e-06	6.63e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CG—hematologic cancer	5.51e-06	6.62e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GBA—hematologic cancer	5.5e-06	6.61e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC35B2—hematologic cancer	5.5e-06	6.61e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK3—hematologic cancer	5.46e-06	6.56e-05	CbGpPWpGaD
Topiramate—Pruritus—Epirubicin—hematologic cancer	5.46e-06	2.48e-05	CcSEcCtD
Topiramate—Dizziness—Methotrexate—hematologic cancer	5.46e-06	2.48e-05	CcSEcCtD
Topiramate—GABRB2—Neuronal System—HRAS—hematologic cancer	5.43e-06	6.52e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	5.37e-06	6.44e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—CREBBP—hematologic cancer	5.33e-06	6.4e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—hematologic cancer	5.3e-06	6.36e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CG—hematologic cancer	5.29e-06	6.34e-05	CbGpPWpGaD
Topiramate—Diarrhoea—Epirubicin—hematologic cancer	5.28e-06	2.4e-05	CcSEcCtD
Topiramate—CA5A—Metabolism—EP300—hematologic cancer	5.26e-06	6.32e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—EP300—hematologic cancer	5.26e-06	6.32e-05	CbGpPWpGaD
Topiramate—Hypersensitivity—Doxorubicin—hematologic cancer	5.26e-06	2.39e-05	CcSEcCtD
Topiramate—Vomiting—Methotrexate—hematologic cancer	5.25e-06	2.38e-05	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—AKT1—hematologic cancer	5.24e-06	6.29e-05	CbGpPWpGaD
Topiramate—Rash—Methotrexate—hematologic cancer	5.2e-06	2.36e-05	CcSEcCtD
Topiramate—Dermatitis—Methotrexate—hematologic cancer	5.2e-06	2.36e-05	CcSEcCtD
Topiramate—Headache—Methotrexate—hematologic cancer	5.17e-06	2.35e-05	CcSEcCtD
Topiramate—CA7—Metabolism—PTEN—hematologic cancer	5.15e-06	6.19e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTEN—hematologic cancer	5.15e-06	6.19e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FTCD—hematologic cancer	5.14e-06	6.17e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PHYH—hematologic cancer	5.14e-06	6.17e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GMPS—hematologic cancer	5.14e-06	6.17e-05	CbGpPWpGaD
Topiramate—Asthenia—Doxorubicin—hematologic cancer	5.13e-06	2.33e-05	CcSEcCtD
Topiramate—CA2—Metabolism—CREBBP—hematologic cancer	5.11e-06	6.14e-05	CbGpPWpGaD
Topiramate—Dizziness—Epirubicin—hematologic cancer	5.11e-06	2.32e-05	CcSEcCtD
Topiramate—CA4—Metabolism—PIK3CD—hematologic cancer	5.05e-06	6.07e-05	CbGpPWpGaD
Topiramate—Pruritus—Doxorubicin—hematologic cancer	5.05e-06	2.3e-05	CcSEcCtD
Topiramate—CYP2C19—Metabolism—MTAP—hematologic cancer	5.03e-06	6.04e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.01e-06	6.01e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—hematologic cancer	4.99e-06	5.99e-05	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—hematologic cancer	4.97e-06	5.97e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—hematologic cancer	4.95e-06	5.94e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—EP300—hematologic cancer	4.91e-06	5.9e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—EP300—hematologic cancer	4.91e-06	5.9e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KRAS—hematologic cancer	4.91e-06	5.9e-05	CbGpPWpGaD
Topiramate—Vomiting—Epirubicin—hematologic cancer	4.91e-06	2.23e-05	CcSEcCtD
Topiramate—CA1—Metabolism—CREBBP—hematologic cancer	4.9e-06	5.88e-05	CbGpPWpGaD
Topiramate—Nausea—Methotrexate—hematologic cancer	4.9e-06	2.23e-05	CcSEcCtD
Topiramate—Diarrhoea—Doxorubicin—hematologic cancer	4.89e-06	2.22e-05	CcSEcCtD
Topiramate—Rash—Epirubicin—hematologic cancer	4.87e-06	2.21e-05	CcSEcCtD
Topiramate—Dermatitis—Epirubicin—hematologic cancer	4.86e-06	2.21e-05	CcSEcCtD
Topiramate—CA2—Metabolism—PIK3CD—hematologic cancer	4.85e-06	5.82e-05	CbGpPWpGaD
Topiramate—Headache—Epirubicin—hematologic cancer	4.84e-06	2.2e-05	CcSEcCtD
Topiramate—CA2—Metabolism—ALB—hematologic cancer	4.78e-06	5.74e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTEN—hematologic cancer	4.77e-06	5.73e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3R1—hematologic cancer	4.77e-06	5.73e-05	CbGpPWpGaD
Topiramate—Dizziness—Doxorubicin—hematologic cancer	4.72e-06	2.15e-05	CcSEcCtD
Topiramate—CYP3A4—Metabolism—SMPD3—hematologic cancer	4.7e-06	5.64e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.69e-06	5.63e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CG—hematologic cancer	4.65e-06	5.58e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CD—hematologic cancer	4.65e-06	5.58e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—hematologic cancer	4.59e-06	5.51e-05	CbGpPWpGaD
Topiramate—Nausea—Epirubicin—hematologic cancer	4.59e-06	2.08e-05	CcSEcCtD
Topiramate—CA2—Metabolism—PIK3R1—hematologic cancer	4.58e-06	5.49e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—EP300—hematologic cancer	4.55e-06	5.47e-05	CbGpPWpGaD
Topiramate—Vomiting—Doxorubicin—hematologic cancer	4.54e-06	2.06e-05	CcSEcCtD
Topiramate—Rash—Doxorubicin—hematologic cancer	4.5e-06	2.05e-05	CcSEcCtD
Topiramate—Dermatitis—Doxorubicin—hematologic cancer	4.5e-06	2.04e-05	CcSEcCtD
Topiramate—CYP2C19—Metabolism—FHL2—hematologic cancer	4.49e-06	5.39e-05	CbGpPWpGaD
Topiramate—Headache—Doxorubicin—hematologic cancer	4.47e-06	2.03e-05	CcSEcCtD
Topiramate—CA4—Metabolism—PIK3CB—hematologic cancer	4.41e-06	5.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AGRN—hematologic cancer	4.4e-06	5.28e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3R1—hematologic cancer	4.39e-06	5.27e-05	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—hematologic cancer	4.34e-06	5.21e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CREBBP—hematologic cancer	4.31e-06	5.17e-05	CbGpPWpGaD
Topiramate—Nausea—Doxorubicin—hematologic cancer	4.24e-06	1.93e-05	CcSEcCtD
Topiramate—CA2—Metabolism—PIK3CB—hematologic cancer	4.22e-06	5.07e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—hematologic cancer	4.17e-06	5.01e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—IDH2—hematologic cancer	4.17e-06	5.01e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMMR—hematologic cancer	4.17e-06	5.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—B3GAT1—hematologic cancer	4.11e-06	4.93e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ASNS—hematologic cancer	4.11e-06	4.93e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DCK—hematologic cancer	4.11e-06	4.93e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CD—hematologic cancer	4.08e-06	4.9e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CB—hematologic cancer	4.05e-06	4.86e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—hematologic cancer	4.03e-06	4.84e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—hematologic cancer	4e-06	4.8e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.93e-06	4.72e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ARNTL—hematologic cancer	3.92e-06	4.71e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—hematologic cancer	3.89e-06	4.67e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—hematologic cancer	3.89e-06	4.67e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HDC—hematologic cancer	3.89e-06	4.67e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3R1—hematologic cancer	3.86e-06	4.63e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA9—hematologic cancer	3.82e-06	4.58e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ACP5—hematologic cancer	3.82e-06	4.58e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTEN—hematologic cancer	3.81e-06	4.57e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOR2—hematologic cancer	3.77e-06	4.52e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—hematologic cancer	3.69e-06	4.42e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTEN—hematologic cancer	3.65e-06	4.38e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—hematologic cancer	3.64e-06	4.36e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—hematologic cancer	3.64e-06	4.36e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—EP300—hematologic cancer	3.63e-06	4.36e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—IDH1—hematologic cancer	3.59e-06	4.31e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CDA—hematologic cancer	3.56e-06	4.27e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CB—hematologic cancer	3.56e-06	4.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCC3—hematologic cancer	3.55e-06	4.26e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TXN—hematologic cancer	3.55e-06	4.26e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTO1—hematologic cancer	3.55e-06	4.26e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTEN—hematologic cancer	3.5e-06	4.2e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—EP300—hematologic cancer	3.48e-06	4.18e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SPHK1—hematologic cancer	3.47e-06	4.17e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PC—hematologic cancer	3.43e-06	4.11e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—hematologic cancer	3.37e-06	4.04e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—EP300—hematologic cancer	3.34e-06	4.01e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—UGT1A1—hematologic cancer	3.33e-06	4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GBA—hematologic cancer	3.31e-06	3.97e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC35B2—hematologic cancer	3.31e-06	3.97e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC22A1—hematologic cancer	3.24e-06	3.89e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CRABP1—hematologic cancer	3.24e-06	3.89e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—hematologic cancer	3.18e-06	3.82e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—hematologic cancer	3.18e-06	3.82e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALOX5—hematologic cancer	3.16e-06	3.79e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTEN—hematologic cancer	3.08e-06	3.69e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NUP98—hematologic cancer	3.06e-06	3.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTAP—hematologic cancer	3.03e-06	3.63e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOA3—hematologic cancer	2.97e-06	3.57e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADCY7—hematologic cancer	2.97e-06	3.57e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—hematologic cancer	2.97e-06	3.57e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—hematologic cancer	2.97e-06	3.57e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NUP214—hematologic cancer	2.95e-06	3.54e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—EP300—hematologic cancer	2.93e-06	3.52e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.92e-06	3.51e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTR—hematologic cancer	2.89e-06	3.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCG2—hematologic cancer	2.89e-06	3.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ENO2—hematologic cancer	2.84e-06	3.4e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—hematologic cancer	2.75e-06	3.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTT1—hematologic cancer	2.75e-06	3.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.71e-06	3.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FHL2—hematologic cancer	2.7e-06	3.24e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SDC1—hematologic cancer	2.69e-06	3.23e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—hematologic cancer	2.69e-06	3.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AGRN—hematologic cancer	2.65e-06	3.18e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—hematologic cancer	2.57e-06	3.09e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.57e-06	3.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.53e-06	3.04e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—IDH2—hematologic cancer	2.51e-06	3.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMMR—hematologic cancer	2.51e-06	3.01e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—hematologic cancer	2.47e-06	2.96e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.42e-06	2.91e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ARNTL—hematologic cancer	2.36e-06	2.83e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ACP5—hematologic cancer	2.29e-06	2.75e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA9—hematologic cancer	2.29e-06	2.75e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CD44—hematologic cancer	2.29e-06	2.74e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NQO1—hematologic cancer	2.29e-06	2.74e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOR2—hematologic cancer	2.26e-06	2.72e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.24e-06	2.69e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—hematologic cancer	2.19e-06	2.63e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—hematologic cancer	2.17e-06	2.61e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYCS—hematologic cancer	2.16e-06	2.6e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—IDH1—hematologic cancer	2.16e-06	2.59e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	2.15e-06	2.58e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TXN—hematologic cancer	2.13e-06	2.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.13e-06	2.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.13e-06	2.56e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—hematologic cancer	2.1e-06	2.53e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.09e-06	2.51e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—hematologic cancer	2.02e-06	2.42e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.01e-06	2.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.95e-06	2.34e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.95e-06	2.34e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.93e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTP1—hematologic cancer	1.91e-06	2.29e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.9e-06	2.28e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.84e-06	2.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NUP98—hematologic cancer	1.84e-06	2.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—hematologic cancer	1.8e-06	2.17e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NUP214—hematologic cancer	1.77e-06	2.13e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—hematologic cancer	1.77e-06	2.13e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOR1—hematologic cancer	1.75e-06	2.1e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—hematologic cancer	1.75e-06	2.1e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.74e-06	2.09e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTR—hematologic cancer	1.74e-06	2.09e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ENO2—hematologic cancer	1.71e-06	2.05e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.65e-06	1.99e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SDC1—hematologic cancer	1.62e-06	1.94e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—hematologic cancer	1.55e-06	1.86e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NQO1—hematologic cancer	1.37e-06	1.65e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CD44—hematologic cancer	1.37e-06	1.65e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.36e-06	1.64e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.3e-06	1.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYCS—hematologic cancer	1.3e-06	1.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.29e-06	1.55e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.21e-06	1.45e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.15e-06	1.38e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.14e-06	1.37e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—hematologic cancer	1.13e-06	1.36e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.09e-06	1.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.08e-06	1.3e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.05e-06	1.26e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.05e-06	1.26e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CB—hematologic cancer	9.97e-07	1.2e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—hematologic cancer	9.31e-07	1.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTEN—hematologic cancer	8.61e-07	1.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—EP300—hematologic cancer	8.21e-07	9.86e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CG—hematologic cancer	7.82e-07	9.39e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CREBBP—hematologic cancer	7.25e-07	8.71e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CD—hematologic cancer	6.88e-07	8.25e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—hematologic cancer	6.79e-07	8.15e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3R1—hematologic cancer	6.49e-07	7.79e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—hematologic cancer	6.08e-07	7.29e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.99e-07	7.19e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTEN—hematologic cancer	5.18e-07	6.22e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—hematologic cancer	4.96e-07	5.96e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—EP300—hematologic cancer	4.94e-07	5.93e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.65e-07	4.39e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—hematologic cancer	2.98e-07	3.58e-06	CbGpPWpGaD
